Nabsys’ Electronic Genome Mapping technology detected clinically relevant genomic abnormalities [...]

Otsuka Pharmaceutical Europe has received an amended European Commission marketing [...]

CERo Therapeutics Holdings, Inc has shared a Phase 1 update [...]

oryzon-iadademstat-aml-alice2-frida-eha-2026 Oryzon Genomics has reported updated Phase 1b data from [...]

Poolbeg Pharma has presented two posters at the European Hematology [...]

AmMax Bio has licensed antibody-drug conjugate technology from Lonza to [...]

The US Food and Drug Administration (FDA) has approved KOMZIFTI [...]

Otsuka Pharmaceutical Europe has submitted a marketing authorisation application (MAA) [...]

Alvarez & Marsal has been appointed as joint administrators of [...]

The US Food and Drug Administration (FDA) has accepted for [...]